CT-guided microinvasive intervention in treating refractory carcinous pain

Area of Science:

• Interventional Radiology
• Pain Management
• Oncology

Background:

• Refractory carcinous pain poses a significant challenge in cancer care, often inadequately managed by conventional therapies.
• Microinvasive interventions offer a less invasive alternative for pain management in cancer patients.
• CT guidance enhances the precision and safety of these interventions.

Purpose of the Study:

• To assess the efficacy of CT-guided microinvasive interventions in alleviating refractory carcinous pain.
• To evaluate the safety profile of these procedures.
• To determine the long-term effectiveness of CT-guided interventions for cancer pain.

Main Methods:

• A cohort of 23 patients with refractory carcinous pain, unresponsive to drug therapy, was studied.
• Interventions included CT-guided neurolytic celiac plexus block (NCPB), CT-guided (125)I implantation, or a combination of both.
• Patient outcomes were assessed based on pain remission, treatment efficiency, and complications.

Main Results:

• High treatment efficiency rates were observed: 82.6% after 1 week and 1 month, 72.2% after 3 months, and 75.0% after 6 months.
• Significant pain reduction was achieved, with complete and partial remission reported in a majority of patients.
• No severe postoperative complications, such as bleeding or fistulas, were reported, indicating a favorable safety profile.

Conclusions:

• CT-guided microinvasive interventions are effective in providing analgesia for refractory carcinous pain.
• These methods offer a less traumatic and safer alternative for managing cancer-related pain.
• The procedures demonstrate a clear benefit in improving the quality of life for patients with advanced cancer pain.